Sign inJoin waitlistJoin the waitlist

Erkut Borazanci

Physician · HonorHealth

Credentials: · · ·

History

HonorHealth
Present

Louisiana State University Health Sciences Center
2011–2013
Internal Medicine
Louisiana State University Health Sciences Center
2008–2011
LSU Medical Center-University Hospital
2008–2011
Louisiana State University and Agricultural & Mechanical College
2004–2008

Research

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine · 2020 · 480 citations
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Nature · 2019 · 366 citations
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors
EClinicalMedicine · 2021 · 276 citations

DH
Daniel Von Hoff
27 papers
RK
Ronald Korn
10 papers
Michael Gordon
5 papers
Randall Brand
5 papers
Susan Tsai
5 papers
Daniel Laheru
4 papers
Douglas Evans
4 papers
Sunil Sharma
4 papers
VC
Vincent Chung
4 papers
Albert Amini
3 papers
Andrew Lowy
3 papers
Angela Alistar
3 papers

Clinical trials

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
Principal investigator · Completed · Phase 2
HonorHealth Research Institute
2022–2025
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Principal investigator · Withdrawn · Phase 2
HonorHealth Research Institute
2022–2025
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
Principal investigator · Completed · Phase 2
HonorHealth Research Institute
2021–2024
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer
Principal investigator · Completed · Phase 2
HonorHealth Research Institute
2020–2025